MACROGENICS INC
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $149.5M | $150.0M | $58.7M | $151.9M | $77.4M |
| Operating income | -$72.8M | -$110.6M | -$168.2M | -$121.4M | -$202.8M |
| Cost of revenue | $0 | $847,000 | $619,000 | $3.4M | $2.7M |
| Cash from operations | -$81.0M | -$68.4M | -$78.2M | -$87.0M | -$143.8M |
| Capital expenditure | $1.9M | $3.7M | $1.8M | $3.6M | $6.2M |
| Free cash flow | -$83.0M | -$72.1M | -$80.0M | -$90.6M | -$150.0M |
| Impairments | $0 | $0 | $0 | — | — |
| Total assets | $256.8M | $261.7M | $298.4M | $280.5M | $335.2M |
| Total liabilities | $201.3M | $145.6M | $145.8M | $138.5M | $95.6M |
Shares outstanding 63.6M · Free float 98.7%
Annual filing data through FY ended December 31, 2025; float as of July 12, 2026.